Global trends in molecular epidemiology of HIV-1 during 2000–2007

Keele, 2006, Chimpanzee reservoirs of pandemic and nonpandemic HIV-1, Science, 313, 523, 10.1126/science.1126531

Worobey, 2008, Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960, Nature, 455, 661, 10.1038/nature07390

Robertson, 2000, HIV-1 nomenclature proposal, Science, 288, 55, 10.1126/science.288.5463.55d

Hemelaar, 2006, Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004, AIDS, 20, W13, 10.1097/01.aids.0000247564.73009.bc

Plantier, 2009, A new human immunodeficiency virus derived from gorillas, Nat Med, 15, 871, 10.1038/nm.2016

Kim, 2007, Short communication: identification of a novel HIV type 1 subtype H/J recombinant in Canada with discordant HIV viral load (RNA) values in three different commercial assays, AIDS Res Hum Retroviruses, 23, 1309, 10.1089/aid.2007.0080

Geretti, 2009, Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy, Clin Infect Dis, 48, 1296, 10.1086/598502

Martinez-Cajas, 2009, Differences in resistance mutations among HIV-1 nonsubtype B infections: a systematic review of evidence (1996–2008), J Int AIDS Soc, 12, 11, 10.1186/1758-2652-12-11

Kiwanuka, 2008, Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection, J Infect Dis, 197, 707, 10.1086/527416

Baeten, 2007, HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads, J Infect Dis, 195, 1177, 10.1086/512682

Vasan, 2006, Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype, Clin Infect Dis, 42, 843, 10.1086/499952

Kiwanuka, 2009, HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda, AIDS, 23, 2479, 10.1097/QAD.0b013e328330cc08

Renjifo, 2004, Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D, AIDS, 18, 1629, 10.1097/01.aids.0000131392.68597.34

Wei, 2003, Antibody neutralization and escape by HIV-1, Nature, 422, 307, 10.1038/nature01470

Goonetilleke, 2009, The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection, J Exp Med, 206, 1253, 10.1084/jem.20090365

Barouch, 2008, Challenges in the development of an HIV-1 vaccine, Nature, 455, 613, 10.1038/nature07352

Korber, 2001, Evolutionary and immunological implications of contemporary HIV-1 variation, Br Med Bull, 58, 19, 10.1093/bmb/58.1.19

Lee, 2004, T cell cross-reactivity and conformational changes during TCR engagement, J Exp Med, 200, 1455, 10.1084/jem.20041251

Gaschen, 2002, Diversity considerations in HIV-1 vaccine selection, Science, 296, 2354, 10.1126/science.1070441

Pitisuttithum, 2006, Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand, J Infect Dis, 194, 1661, 10.1086/508748

Buchbinder, 2008, Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial, Lancet, 372, 1881, 10.1016/S0140-6736(08)61591-3

Rerks-Ngarm, 2009, Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand, N Engl J Med, 361, 2209, 10.1056/NEJMoa0908492

Arien, 2007, Is HIV-1 evolving to a less virulent form in humans?, Nat Rev Microbiol, 5, 141, 10.1038/nrmicro1594

Rainwater, 2005, No evidence for rapid subtype C spread within an epidemic in which multiple subtypes and intersubtype recombinants circulate, AIDS Res Hum Retroviruses, 21, 1060, 10.1089/aid.2005.21.1060

Gray, 2009, Spatial phylodynamics of HIV-1 epidemic emergence in east Africa, AIDS, 23, F9, 10.1097/QAD.0b013e32832faf61

Corey, 2010, HIV vaccines: mosaic approach to virus diversity, Nat Med, 16, 268, 10.1038/nm0310-268